US FDA Bioresearch Monitoring Program’s Reliance On Remote Assessment Tools Grows

 
• By Sue Sutter
  
Laptop
The pandemic has driven an increase in FDA's use of remote assessment tools for bioresearch monitoring. • Source: Alamy

More from Clinical Trials

More from R&D